Relationship between DPP-4is plus metformin versus SUs plus metformin on the risk of MACE and mortality in included studies.

Relationship between DPP-4is plus metformin versus SUs plus metformin on the risk of MACE and mortality in included studies.纳入研究中，二肽基肽酶-4抑制剂（DPP-4is）联合二甲双胍与磺脲类药物（SUs）联合二甲双胍相比，在主要不良心血管事件（MACE）及死亡风险方面的关联。